LOADING
Comparing Eli Lilly and Company (LLY) and Mastercard Inc (MA) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | MA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $1.03T | $502.0B |
| P/E Ratio | 40.8 | 31.5 |
| Forward P/E | 33.9 | 29.1 |
| PEG Ratio | 1.61 | 1.76 |
| EPS | $28.15 | $18.17 |
| Revenue Growth (YoY) | 55.5% | 14.1% |
| Profit Margin | 35.0% | 46.3% |
| Return on Equity | 107.5% | 241.2% |
| Dividend Yield | 0.54% | 0.58% |
| Beta | 0.51 | 0.73 |
| 52-Week High | $1,249.45 | $598.04 |
| 52-Week Low | $619.40 | $463.74 |
| Volume | -- | -- |
Eli Lilly and Company is the larger company by market capitalization. Mastercard Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Mastercard Inc offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.